Thomas J. Montine, MD PhD - Related publications

Pathology University of Washington, Seattle, Seattle, WA 
NOTE: We are testing a new system for identifying relevant work based on semantic analysis that identifies similarities between recently published papers and the current author's publications. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches.
50 most relevant papers in past 60 days:
Year Citation  Score
2019 Boese AC, Hamblin MH, Lee JP. Neural stem cell therapy for neurovascular injury in Alzheimer's disease. Experimental Neurology. 113112. PMID 31730762 DOI: 10.1016/j.expneurol.2019.113112   
2019 Kumar D, Kumar P. Aβ, Tau, and α-Synuclein aggregation and integrated role of PARK2 in the regulation and clearance of toxic peptides. Neuropeptides. 101971. PMID 31540705 DOI: 10.1016/j.npep.2019.101971   
2019 Grimaldi A, Pediconi N, Oieni F, Pizzarelli R, Rosito M, Giubettini M, Santini T, Limatola C, Ruocco G, Ragozzino D, Di Angelantonio S. Neuroinflammatory Processes, A1 Astrocyte Activation and Protein Aggregation in the Retina of Alzheimer's Disease Patients, Possible Biomarkers for Early Diagnosis. Frontiers in Neuroscience. 13: 925. PMID 31551688 DOI: 10.3389/fnins.2019.00925   
2019 Sun X, Nie B, Zhao S, Chen Q, Li P, Zhang T, Pan T, Feng T, Wang L, Yin X, Zhang W, Zhao S, Shan B, Liu H, Liang S, et al. Tau PET distributional pattern in AD patients with visuospatial dysfunction. Current Alzheimer Research. PMID 31724513 DOI: 10.2174/1567205016666191113152434   
2019 Gámez-Valero A, Campdelacreu J, Vilas D, Ispierto L, Reñé R, Álvarez R, Armengol MP, Borràs FE, Beyer K. Exploratory study on microRNA profiles from plasma-derived extracellular vesicles in Alzheimer's disease and dementia with Lewy bodies. Translational Neurodegeneration. 8: 31. PMID 31592314 DOI: 10.1186/s40035-019-0169-5   
2019 Potashkin JA, Bottero V, Santiago JA, Quinn JP. Computational identification of key genes that may regulate gene expression reprogramming in Alzheimer's patients. Plos One. 14: e0222921. PMID 31545826 DOI: 10.1371/journal.pone.0222921   
2019 de Souza LC, Mariano LI, de Moraes RF, Caramelli P. Behavioral variant of frontotemporal dementia or frontal variant of Alzheimer's disease? A case study. Dementia & Neuropsychologia. 13: 356-360. PMID 31555411 DOI: 10.1590/1980-57642018dn13-030015   
2019 Polis B, Gurevich V, Assa M, Samson AO. Norvaline Restores the BBB Integrity in a Mouse Model of Alzheimer's Disease. International Journal of Molecular Sciences. 20. PMID 31540372 DOI: 10.3390/ijms20184616   
2019 Zhang H, Zheng Y. [β Amyloid Hypothesis in Alzheimer's Disease:Pathogenesis,Prevention,and Management]. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. Acta Academiae Medicinae Sinicae. 41: 702-708. PMID 31699204 DOI: 10.3881/j.issn.1000-503X.10875   
2019 McRae-McKee K, Udeh-Momoh CT, Price G, Bajaj S, de Jager CA, Scott D, Hadjichrysanthou C, McNaughton E, Bracoud L, Ahmadi-Abhari S, de Wolf F, Anderson RM, Middleton LT, . Perspective: Clinical relevance of the dichotomous classification of Alzheimer's disease biomarkers: Should there be a "gray zone"? Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 31564609 DOI: 10.1016/j.jalz.2019.07.010   
2019 Canevelli M, Bacigalupo I, Gervasi G, Lacorte E, Massari M, Mayer F, Vanacore N, Cesari M. Methodological Issues in the Clinical Validation of Biomarkers for Alzheimer's Disease: The Paradigmatic Example of CSF. Frontiers in Aging Neuroscience. 11: 282. PMID 31680936 DOI: 10.3389/fnagi.2019.00282   
2019 Verkhratsky A, Parpura V, Rodriguez-Arellano JJ, Zorec R. Astroglia in Alzheimer's Disease. Advances in Experimental Medicine and Biology. 1175: 273-324. PMID 31583592 DOI: 10.1007/978-981-13-9913-8_11   
2019 Park JC, Han SH, Lee H, Jeong H, Byun MS, Bae J, Kim H, Young Lee D, Yi D, Shin SA, Kim YK, Hwang D, Lee SW, Mook-Jung I. Prognostic plasma protein panel for Aβ deposition in the brain in Alzheimer's disease. Progress in Neurobiology. 101690. PMID 31605717 DOI: 10.1016/j.pneurobio.2019.101690   
2019 Tsai CL, Liang CS, Lee JT, Su MW, Lin CC, Chu HT, Tsai CK, Lin GY, Lin YK, Yang FC. Associations between Plasma Biomarkers and Cognition in Patients with Alzheimer's Disease and Amnestic Mild Cognitive Impairment: A Cross-Sectional and Longitudinal Study. Journal of Clinical Medicine. 8. PMID 31698867 DOI: 10.3390/jcm8111893   
2019 Caruso A, Nicoletti F, Gaetano A, Scaccianoce S. Risk Factors for Alzheimer's Disease: Focus on Stress. Frontiers in Pharmacology. 10: 976. PMID 31551781 DOI: 10.3389/fphar.2019.00976   
2019 Burns DK, Chiang C, Welsh-Bohmer KA, Brannan SK, Culp M, O'Neil J, Runyan G, Harrigan P, Plassman BL, Lutz M, Lai E, Haneline S, Yarnall D, Yarbrough D, Metz C, et al. The TOMMORROW study: Design of an Alzheimer's disease delay-of-onset clinical trial. Alzheimer's & Dementia (New York, N. Y.). 5: 661-670. PMID 31720367 DOI: 10.1016/j.trci.2019.09.010   
2019 Li TR, Wang XN, Sheng C, Li YX, Li FZ, Sun Y, Han Y. Extracellular vesicles as an emerging tool for the early detection of Alzheimer's disease. Mechanisms of Ageing and Development. 111175. PMID 31678325 DOI: 10.1016/j.mad.2019.111175   
2019 Michelson D, Grundman M, Magnuson K, Fisher R, Levenson JM, Aisen P, Marek K, Gray M, Hefti F. Randomized, Placebo Controlled Trial of NPT088, A Phage-Derived, Amyloid-Targeted Treatment for Alzheimer's Disease. The Journal of Prevention of Alzheimer's Disease. 6: 228-231. PMID 31686093 DOI: 10.14283/jpad.2019.37   
2019 Liu C, Yu J. Genome-Wide Association Studies for Cerebrospinal Fluid Soluble TREM2 in Alzheimer's Disease. Frontiers in Aging Neuroscience. 11: 297. PMID 31708768 DOI: 10.3389/fnagi.2019.00297   
2019 Castora FJ, Conyers BL, Gershon BS, Kerns KA, Campbell R, Simsek-Duran F. The T9861C Mutation in the mtDNA-Encoded Cytochrome C Oxidase Subunit III Gene Occurs in High Frequency but with Unequal Distribution in the Alzheimer's Disease Brain. Journal of Alzheimer's Disease : Jad. PMID 31561357 DOI: 10.3233/JAD-190176   
2019 Liu YS, Yan WJ, Tan CC, Li JQ, Xu W, Cao XP, Tan L, Yu JT, . Common Variant in TREM1 Influencing Brain Amyloid Deposition in Mild Cognitive Impairment and Alzheimer's Disease. Neurotoxicity Research. PMID 31721052 DOI: 10.1007/s12640-019-00105-y   
2019 Liu YS, Yan WJ, Tan CC, Li JQ, Xu W, Cao XP, Tan L, Yu JT, . Common Variant in TREM1 Influencing Brain Amyloid Deposition in Mild Cognitive Impairment and Alzheimer's Disease. Neurotoxicity Research. PMID 31721052 DOI: 10.1007/s12640-019-00105-y   
2019 Liu PP, Xie Y, Meng XY, Kang JS. History and progress of hypotheses and clinical trials for Alzheimer's disease. Signal Transduction and Targeted Therapy. 4: 29. PMID 31637009 DOI: 10.1038/s41392-019-0063-8   
2019 Dhakal S, Kushairi N, Phan CW, Adhikari B, Sabaratnam V, Macreadie I. Dietary Polyphenols: A Multifactorial Strategy to Target Alzheimer's Disease. International Journal of Molecular Sciences. 20. PMID 31615073 DOI: 10.3390/ijms20205090   
2019 Foley KE, Yang HS, Graham LC, Howell GR. Transcriptional profiling predicts running promotes cerebrovascular remodeling in young but not midlife mice. Bmc Genomics. 20: 860. PMID 31726991 DOI: 10.1186/s12864-019-6230-z   
2019 Luo X, Li K, Zeng Q, Huang P, Jiaerken Y, Wang S, Shen Z, Xu X, Xu J, Wang C, Kong L, Zhou J, Zhang M. Application of T1-/T2-Weighted Ratio Mapping to Elucidate Intracortical Demyelination Process in the Alzheimer's Disease Continuum. Frontiers in Neuroscience. 13: 904. PMID 31551678 DOI: 10.3389/fnins.2019.00904   
2019 Schwartz M, Arad M, Ben-Yehuda H. Potential immunotherapy for Alzheimer disease and age-related dementia. Dialogues in Clinical Neuroscience. 21: 21-25. PMID 31607777   
2019 Anila V, Mahalaxmi I, Venkatesh B, Balachandar V. Mitochondrial Calcium Uniporter as a potential therapeutic strategy for Alzheimer's disease (AD). Acta Neuropsychiatrica. 1-19. PMID 31556366 DOI: 10.1017/neu.2019.39   
2019 Kang SH, Park YH, Lee D, Kim JP, Chin J, Ahn Y, Park SB, Kim HJ, Jang H, Jung YH, Kim J, Lee J, Kim JS, Cheon BK, Hahn A, et al. The Cortical Neuroanatomy Related to Specific Neuropsychological Deficits in Alzheimer's Continuum. Dementia and Neurocognitive Disorders. 18: 77-95. PMID 31681443 DOI: 10.12779/dnd.2019.18.3.77   
2019 Long JM, Holtzman DM. Alzheimer Disease: An Update on Pathobiology and Treatment Strategies. Cell. 179: 312-339. PMID 31564456 DOI: 10.1016/j.cell.2019.09.001   
2019 Gottesman RT, Stern Y. Behavioral and Psychiatric Symptoms of Dementia and Rate of Decline in Alzheimer's Disease. Frontiers in Pharmacology. 10: 1062. PMID 31616296 DOI: 10.3389/fphar.2019.01062   
2019 Ahmad SS, Khan S, Kamal MA, Wasi U. The structure and function of α, β and γ-Secretase as therapeutic target enzymes into the development of Alzheimer's disease: A review. Cns & Neurological Disorders Drug Targets. PMID 31608840 DOI: 10.2174/1871527318666191011145941   
2019 Carandini T, Arighi A, Sacchi L, Fumagalli GG, Pietroboni AM, Ghezzi L, Colombi A, Scarioni M, Fenoglio C, De Riz MA, Marotta G, Scarpini E, Galimberti D. Testing the 2018 NIA-AA research framework in a retrospective large cohort of patients with cognitive impairment: from biological biomarkers to clinical syndromes. Alzheimer's Research & Therapy. 11: 84. PMID 31615545 DOI: 10.1186/s13195-019-0543-7   
2019 Webers A, Heneka MT, Gleeson PA. The role of innate immune responses and neuroinflammation in amyloid accumulation and progression of Alzheimer's disease. Immunology and Cell Biology. PMID 31654430 DOI: 10.1111/imcb.12301   
2019 A Armstrong R. Risk factors for Alzheimer's disease. Folia Neuropathologica. 57: 87-105. PMID 31556570 DOI: 10.5114/fn.2019.85929   
2019 Kisby B, Jarrell JT, Agar ME, Cohen DS, Rosin ER, Cahill CM, Rogers JT, Huang X. Alzheimer's Disease and Its Potential Alternative Therapeutics. Journal of Alzheimer's Disease & Parkinsonism. 9. PMID 31588368 DOI: 10.4172/2161-0460.1000477   
2019 Arboleda-Velasquez JF, Lopera F, O'Hare M, Delgado-Tirado S, Marino C, Chmielewska N, Saez-Torres KL, Amarnani D, Schultz AP, Sperling RA, Leyton-Cifuentes D, Chen K, Baena A, Aguillon D, Rios-Romenets S, et al. Resistance to autosomal dominant Alzheimer's disease in an APOE3 Christchurch homozygote: a case report. Nature Medicine. PMID 31686034 DOI: 10.1038/s41591-019-0611-3   
2019 Iqbal K, Liu F, Gong C, Dai C, Hu W. Why delay in effective treatment for Alzheimer's disease and related conditions. Progress in Molecular Biology and Translational Science. 168: 243-256. PMID 31699318 DOI: 10.1016/bs.pmbts.2019.08.002   
2019 Smilnak GJ, Deans JR, Doraiswamy PM, Stinnett S, Whitson HE, Lad EM. Comorbidity of age-related macular degeneration with Alzheimer's disease: A histopathologic case-control study. Plos One. 14: e0223199. PMID 31568508 DOI: 10.1371/journal.pone.0223199   
2019 Liu K, Ma C, Su J, Sun Y, Shen N, Li B, Feng Y, Yang X, Wu H, Zhang H, Herrmann A, Tanzi R, Zhang C. Significant upregulation of Alzheimer's β-amyloid levels in living system induced by extracellular elastin polypeptides. Angewandte Chemie (International Ed. in English). PMID 31609093 DOI: 10.1002/anie.201912399   
2019 Chai B, Gao F, Wu R, Dong T, Gu C, Lin Q, Zhang Y. Vitamin D deficiency as a risk factor for dementia and Alzheimer's disease: an updated meta-analysis. Bmc Neurology. 19: 284. PMID 31722673 DOI: 10.1186/s12883-019-1500-6   
2019 Chen X, Xu B, Nie L, He K, Zhou L, Huang X, Spencer P, Yang X, Liu J. Flavanol-rich lychee fruit extract substantially reduces progressive cognitive and molecular deficits in a triple-transgenic animal model of Alzheimer disease. Nutritional Neuroscience. 1-15. PMID 31603034 DOI: 10.1080/1028415X.2019.1673527   
2019 Colloby SJ, Watson R, Blamire AM, O'Brien JT, Taylor JP. Cortical thinning in dementia with Lewy bodies and Parkinson disease dementia. The Australian and New Zealand Journal of Psychiatry. 4867419885165. PMID 31696728 DOI: 10.1177/0004867419885165   
2019 Sacino AN, Prokop S, Walsh MA, Adamson J, Subramony SH, Krans A, Todd PK, Giasson BI, Yachnis AT. Fragile X-associated tremor ataxia syndrome with co-occurrent progressive supranuclear palsy-like neuropathology. Acta Neuropathologica Communications. 7: 158. PMID 31665069 DOI: 10.1186/s40478-019-0818-z   
2019 Eruysal E, Ravdin L, Kamel H, Iadecola C, Ishii M. Plasma lipocalin-2 levels in the preclinical stage of Alzheimer's disease. Alzheimer's & Dementia (Amsterdam, Netherlands). 11: 646-653. PMID 31517027 DOI: 10.1016/j.dadm.2019.07.004   
2019 Bianchi VE, Herrera PF, Laura R. Effect of nutrition on neurodegenerative diseases. A systematic review. Nutritional Neuroscience. 1-25. PMID 31684843 DOI: 10.1080/1028415X.2019.1681088   
2019 Karim N, Khan H, Khan I, Guo O, Sanchez ES, Rastrelli L, Kamal MA. An increasing role of polyphenols as novel therapeutics for Alzheimer's: A review. Medicinal Chemistry (Shariqah (United Arab Emirates)). PMID 31702507 DOI: 10.2174/1573406415666191105154407   
2019 Pereira CF, Santos AE, Moreira PI, Pereira AC, Sousa FJ, Cardoso SM, Cruz MT. Is Alzheimer's disease an inflammasomopathy? Ageing Research Reviews. 100966. PMID 31577960 DOI: 10.1016/j.arr.2019.100966   
2019 Shin WS, Di J, Cao Q, Li B, Seidler PM, Murray KA, Bitan G, Jiang L. Amyloid β-protein oligomers promote the uptake of tau fibril seeds potentiating intracellular tau aggregation. Alzheimer's Research & Therapy. 11: 86. PMID 31627745 DOI: 10.1186/s13195-019-0541-9   
2019 Chan HH, Koh RY, Lim CL, Leong CO. Receptor-Interacting Protein Kinase 1 (RIPK1) as a Potential Therapeutic Target: An Overview of Its Possible Role in the Pathogenesis of Alzheimer's Disease. Current Alzheimer Research. PMID 31642777 DOI: 10.2174/1567205016666191023102422